Company Overview - Helix Acquisition Corp. III is a special purpose acquisition company (SPAC) formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses [3] - The company intends to focus on opportunities in healthcare or healthcare-related industries [3] - The company is sponsored by Helix Holdings III LLC, an affiliate of Cormorant Asset Management, and is led by Bihua Chen as CEO and Chairperson, and Caleb Tripp as CFO and COO [3] Initial Public Offering (IPO) - On January 26, 2026, the company closed its initial public offering of 17,250,000 Class A ordinary shares, including 2,250,000 shares from the underwriters' over-allotment option [2] - The offering was priced at $10.00 per share, resulting in gross proceeds of $172,500,000 before deducting underwriting discounts and commissions [2][4] - The Class A ordinary shares began trading on The Nasdaq Global Market under the ticker symbol "HLXC" on January 23, 2026 [4] Private Placement - Concurrently with the IPO, the company completed a private placement of 497,500 Class A ordinary shares at a price of $10.00 per share, generating gross proceeds of $4,975,000 [4] - A total of $172,500,000 from the IPO and private placement was placed in trust [6] Regulatory and Compliance - A registration statement relating to these securities was declared effective by the SEC on January 22, 2026 [7] - An audited balance sheet reflecting the receipt of proceeds from the IPO and private placement will be included in a Current Report on Form 8-K to be filed with the SEC [6]
Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares